Hengyongda

Company Introduction of Shenzhen Hengyongda Technology Joint-stock Co., Ltd.

Since its establishment in 2012, Hengyongda Technology has been adhering to the purpose and philosophy of deeply understanding the actual needs of designers of global automated analytical instruments, studying the difficulties and pain points in microfluidic system design, providing customers with * reasonable and reliable products and system solutions, and enabling them to reach the world's excellent level. It focuses on the research and development of millimeter-level microfluidic components and system solutions, and has independently developed and produced key microfluidic components including precision plunger pumps, precision metering pumps, solenoid valves, sampling needles, medical rubber and plastic tubes, pipeline connectors, multi-channel rotary valves, miniature diaphragm pumps, air pipetting pumps, etc., which effectively support the liquid path needs in fields such as life support, gene sequencing, single-cell sorting, chemiluminescence, and chromatography-mass spectrometry, and also provide the industry with highly cost-effective solutions.
Since its establishment, the company has reached cooperation with hundreds of companies at home and abroad, with annual sales of nearly 100 million yuan, growing into a pioneer in the microfluidic industry segment, and is also one of the microfluidic component manufacturers with relatively high technical level, relatively large scale, and * complete product specifications in China, becoming an indispensable presence in the microfluidic component industry. The plunger pumps, sampling needles and other products produced by the company have achieved replacement of international brands, gradually solving the technical bottlenecks and bottleneck problems of high-end key components in the medical device and environmental protection industries, and providing customers with a package of domestic substitution solutions for key microfluidic components.
In the sudden outbreak of the anti-epidemic war in 2020, the company recalled employees within Guangdong Province at the * time, and at the same time contacted employees outside the province to gradually return to the team under the condition of ensuring safety, organized emergency production, and began overtime production successively in early February 2020, working day and night. Under the condition of supply cutoff of foreign brands, it provided a large number of key components such as diaphragm pumps, plunger pumps, and sampling needles to domestic monitoring equipment and in vitro diagnostic equipment manufacturers. As core components of medical equipment, the company's products indirectly enabled hundreds of thousands of patients to receive timely rescue and treatment, provided a solid guarantee for patients' life safety, and also contributed strength to China's victory in the anti-epidemic fight. We are extremely proud to contribute at a time of national crisis.
As a national high-tech enterprise, as well as an industry-university-research base of Southern University of Science and Technology, Nanjing University of Science and Technology, Shenzhen University, etc., the company attaches great importance to independent innovation and research and development, with R&D personnel accounting for 30% and R&D investment accounting for 20%. Continuous R&D investment has enabled the company's average compound growth rate to reach more than 40%.
In recent years, through the efforts of all employees, the company has obtained nearly 60 various patent rights and copyrights. What is more encouraging is that the Shenzhen major scientific and technological research project (Zhong 2019N045 Key Technology Research and Development of High-precision Sampling Needles for High-end IVD Equipment) in which the company participated has made breakthrough progress after years of efforts. The breakthrough of this project means that the company may rank among the world's excellent suppliers in the sampling needle segment, breaking a shackle that foreign suppliers have long placed on the necks of domestic IVD enterprises.
In 2021, the company won the title of Guangdong Province Specialized, Refined, Special and New Enterprise, which is the customer's recognition of the company, an affirmation of the company's development over the past decade, and also a spur to Hengyongda. In 2022, the company completed the joint-stock reform and leased a brand-new factory in Guangming New District to expand production.
The strong pass is like iron, yet now we step forward from the beginning. All Hengyongda people will remain true to our original aspiration, forge ahead, move toward more ambitious goals, and jointly write new chapters for the harmony and health of human society!